Promoting Respiratory Motor Recovery After Cervical Spinal Cord Injury with PTP Sigma Receptor Blockade

Grants and Contracts Details

StatusActive
Effective start/end date5/1/233/31/25

Funding

  • Nervgen Pharma Corporation: $109,092.00